| Filed On | Filing |
|---|---|
| 28 Sep 2026 |
Form 4: Binder Steven B., Director
Sold 39,051 shares ($128K) |
| 25 Sep 2026 | 144 |
| 14 Sep 2026 |
Form 4: Binder Steven B., Director
Sold 33,558 shares ($128K) |
| 10 Sep 2026 | 144 |
| 21 Aug 2026 | 424B7 |
| 21 Aug 2026 | 8-K: Other Events |
| 14 Aug 2026 | SCHEDULE 13G |
| 10 Aug 2026 |
Form 4: Binder Steven B., Director
Sold 39,051 shares ($159K) |
| 07 Aug 2026 | 144 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 31 Jul 2026 | SCHEDULE 13G |
| 24 Jul 2026 | 8-K: Unregistered Sales of Equity Securities; Other Events |
| 17 Jul 2026 |
Form 4: Prentiss Christopher B, Chief Financial Officer
Gave up 22,247 shares to cover exercise price or tax ($91K) |
| 17 Jul 2026 |
Form 4: Marasco Dominic, Pres, Endocrine Business Unit
Gave up 3,623 shares to cover exercise price or tax ($14.8K) |
| 17 Jul 2026 |
Form 4: Tross Stuart A, Chief People & Workpl Officer
Received 93,790 shares by exercise or conversion · Gave up 65,808 shares to cover exercise price or tax ($269K) |
| 17 Jul 2026 |
Form 4: Castagna Michael, Director
Received 350,260 shares by exercise or conversion · Gave up 363,200 shares to cover exercise price or tax ($1.49M) |
| 17 Jul 2026 |
Form 4: Singh Sanjay R, EVP Technical Operations
Received 70,550 shares by exercise or conversion · Gave up 46,795 shares to cover exercise price or tax ($191K) |
| 17 Jul 2026 |
Form 4: Thomson David, EVP Genl Counsel & Secretary
Received 93,790 shares by exercise or conversion · Gave up 98,426 shares to cover exercise price or tax ($403K) · Sold 24,109 shares ($97.6K) |
| 17 Jul 2026 |
Form 4: Binder Steven B., Director
Received 93,790 shares by exercise or conversion · Gave up 24,395 shares to cover exercise price or tax ($99.8K) · Sold 52,485 shares ($213K) |
Loading...